# Inhibrx Biosciences, Inc.: Form 8-K, filed Jul 16, 2026

- Company: [Inhibrx Biosciences, Inc.](/companies/inbx.md) (CIK 2007919)
- Form: 8-K
- Filed: 2026-07-16
- Accepted by EDGAR: Jul 16, 2026, 16:06 ET
- Period: 2026-07-15
- Accession: 0002007919-26-000037
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2007919/000200791926000037/inhibrx-20260715.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2007919/000200791926000037/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2007919/000200791926000037/inhibrx-20260715.htm

Filed Jul 16, 2026.
Source: SEC EDGAR, the filing index for accession 0002007919-26-000037. Last ingested by Listed: Nov 14, 2026, 21:07 ET. No prices; not investment advice.
